Congenital adrenal hyperplasia
GPTKB entity
Statements (54)
Predicate | Object |
---|---|
gptkbp:instanceOf |
genetic disorder
metabolic disorder |
gptkbp:affects |
adrenal glands
both males and females |
gptkbp:associatedWith |
gptkb:hypoglycemia
short stature dehydration failure to thrive virilization polycystic ovaries electrolyte imbalance hyperpigmentation oligomenorrhea hypertension (in some forms) testicular adrenal rest tumors |
gptkbp:canBe |
classic form
late-onset form non-classic form salt-wasting form simple virilizing form |
gptkbp:canBeManagedBy |
lifelong hormone replacement
stress dose steroids surgical correction (in some cases) |
gptkbp:cause |
infertility
hirsutism adrenal crisis salt-wasting crisis precocious puberty ambiguous genitalia 11β-hydroxylase deficiency 17α-hydroxylase deficiency 3β-hydroxysteroid dehydrogenase deficiency lipoid CAH |
gptkbp:causedBy |
enzyme deficiency
|
gptkbp:detects |
elevated 17-hydroxyprogesterone
|
gptkbp:diagnosedBy |
genetic testing
hormone testing newborn screening |
gptkbp:firstDescribed |
1950
|
https://www.w3.org/2000/01/rdf-schema#label |
Congenital adrenal hyperplasia
|
gptkbp:ICD-10_code |
E25.0
|
gptkbp:inheritance |
autosomal recessive
|
gptkbp:MeSH_ID |
D000311
|
gptkbp:monitors |
hormone levels
growth monitoring electrolyte levels |
gptkbp:mostCommonCause |
gptkb:21-hydroxylase_deficiency
|
gptkbp:OMIM |
201910
|
gptkbp:prevalence |
1 in 10,000 to 1 in 20,000 live births
|
gptkbp:treatment |
gptkb:glucocorticoids
mineralocorticoids |
gptkbp:bfsParent |
gptkb:chromosome_10
gptkb:Adrenal_Gland |
gptkbp:bfsLayer |
6
|